Skip to content

Clinical trials

Genital Neoplasms, Male trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genital Neoplasms, Male Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20083
20092
20114
20132
20143
20153
20161
20172
20182
20203
20215
20221
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated9
Recruiting5
Active, not recruiting4
Unknown status4
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Steba Biotech S.A.6
Advanced Accelerator Applications2
NanOlogy, LLC2
Novartis Pharmaceuticals2
Alessandro D'Agnolo1
Aragon Pharmaceuticals, Inc.1
Arno Therapeutics1
Astellas Pharma Global Development, Inc.1
Australian and New Zealand Urogenital and Prostate Cancer Trials Group1
Cedars-Sinai Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genital Neoplasms, Male40
Prostatic Neoplasms38
Urogenital Neoplasms35
Prostatic Diseases26
Neoplasms23
Neoplasms by Site21
Genital Diseases, Male19
Male Urogenital Diseases10
Carcinoma8
Genital Diseases5

Trials

Showing 26 to 40 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.